Dr. Justin William Ady, MD

Dr. Ady practices at Robert Wood Johnson University Hospital in New Brunswick, New Jersey, part of RWJBarnabas Health.

Dr. Ady's NPI, 1558664599, was assigned on December 14, 2010. Dr. Ady graduated from Albert Einstein College of Medicine of Yeshiva University in 2010. Dr. Ady holds New Jersey license 25MA10140900.

Dr. Ady's primary practice is Robert Wood Johnson University Hospital, at One Robert Wood Johnson Place, New Brunswick, NJ 08901 in Middlesex County. The practice phone is (732) 828-3000. Dr. Ady also practices at Robert Wood Johnson University Hospital - New Brunswick, 1 Robert Wood Johnson Pl, New Brunswick, NJ 08901.

Dr. Ady's primary practice is Robert Wood Johnson University Hospital in New Brunswick, New Jersey, part of RWJBarnabas Health. Dr. Ady is also affiliated with JFK University Medical Center. The medical group on file is Rutgers Robert Wood Johnson Medical Group. Dmand AI also links Dr. Ady to 3 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ady practices, 5 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Ady's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Ady is licensed in New Jersey.

CMS data shows 1,972 Medicare services from Dr. Ady across 17 procedure codes in 2024, for 1,300 Medicare patients. Medicare paid $67,664 for them.

CMS counts 1,300 Medicare patients who saw Dr. Ady in 2024. The largest group is 75 to 84, with 480 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 21% are also on Medicaid. Their average risk score is 2.54, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ady's median patient age at 72, with 44% women.

In 2024, Dr. Ady wrote 112 Medicare Part D claims for 44 patients. 69% of them were for generic drugs. CMS names the drug for 52 of them, across 2 drugs with 11 or more claims each, at $18,543 in total drug cost. In 2023, CMS named 57 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Ady for performance year 2024, reported as part of a group. Dr. Ady accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Ady as offering telehealth. CMS counts 69 procedures of removal of tissue by Dr. Ady, more than 82% of the clinicians it reports for that procedure.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 13 papers to Dr. Ady, published from 2013 to 2023. 2014 was the busiest year, with 5. The most frequent topics are Aortic Aneurysm, Abdominal, Cell Line, Tumor and Endovascular Procedures. Dr. Ady has published most often in J Vasc Surg. Dr. Ady's most frequent co-authors are Laurence Justin Belin, MD, MPH, Yuman Fong, MD and Saum Amir Rahimi, MD.

CMS Open Payments shows 212 general payments to Dr. Ady from 30 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 79% of the total. Bolton Medical Inc paid the most, $5,839.

Dr. Ady graduated from Albert Einstein College of Medicine of Yeshiva University in 2010.